Food Advisory Committee divided on whether ephedrine safe dose can be identified.
This article was originally published in The Tan Sheet
Executive Summary
EPHEDRINE ALKALOID SUPPLEMENT SAFE DOSE CANNOT BE IDENTIFIED or might be found at a very low level, members of FDA's Food Advisory Committee concluded in an informal "poll" taken at the group's Aug. 27-28 meeting in Washington, D.C. The members were divided into two camps on whether a safe dose for ephedrine alkaloids in dietary supplements could be identified.
You may also be interested in...
FDA Appeals Utah Ephedra Court Ruling, Defends Use Of Risk/Benefit Analysis
FDA's use of a risk/benefit analysis to show that ephedra presented an "unreasonable risk of illness or injury" was an appropriate means of supporting the ban of the ingredient in 2004, according to the agency
FDA Appeals Utah Ephedra Court Ruling, Defends Use Of Risk/Benefit Analysis
FDA's use of a risk/benefit analysis to show that ephedra presented an "unreasonable risk of illness or injury" was an appropriate means of supporting the ban of the ingredient in 2004, according to the agency
FDA Appeals Utah Ephedra Court Ruling, Defends Use Of Risk/Benefit Analysis
FDA's use of a risk/benefit analysis to show that ephedra presented an "unreasonable risk of illness or injury" was an appropriate means of supporting the ban of the ingredient in 2004, according to the agency